CryoPort Inc. Common Stock (CYRX)
Stock · NASDAQ · Health Care
$16.09as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$8.16
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $780.73M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How CryoPort Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 5, 2026 · via SEC EDGAR / Finnhub
CryoPort Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CYRXCryoPort Inc. Common Stock$16.08▼ 2.96%Market cap $780.73MP/E —
- ACRSAclaris Therapeutics Inc. Common Stock$6.01▼ 2.44%Market cap $772.34MP/E —$1.74$6.6
- PHARPharming Group N.V. ADS each representing 10 ordinary shares$11.7▼ 0.68%Market cap $766.28MP/E 88.15$0.8338$1.82
- DSGNDesign Therapeutics Inc. Common Stock$15.12▼ 0.85%Market cap $796.95MP/E —$5.04$17.25
- MNPRMonopar Therapeutics Inc. Common Stock$112.17▼ 1.55%Market cap $747.88MP/E —$32.04$124.82
- GERNGeron Corporation Common Stock$1.51▼ 1.63%Market cap $821.15MP/E —$1.04$2.01
- DRUGBright Minds Biosciences Inc. Common Stock$72.74▼ 2.41%Market cap $723.93MP/E —$53.99$170
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CYRX CryoPort Inc. Common Stock | $780.73M | — | $16.08 | ▼ 2.96% | |
| ACRS Aclaris Therapeutics Inc. Common Stock | $772.34M | — | $6.01 | ▼ 2.44% | $1.74$6.6 |
| PHAR Pharming Group N.V. ADS each representing 10 ordinary shares | $766.28M | 88.15 | $11.7 | ▼ 0.68% | $0.8338$1.82 |
| DSGN Design Therapeutics Inc. Common Stock | $796.95M | — | $15.12 | ▼ 0.85% | $5.04$17.25 |
| MNPR Monopar Therapeutics Inc. Common Stock | $747.88M | — | $112.17 | ▼ 1.55% | $32.04$124.82 |
| GERN Geron Corporation Common Stock | $821.15M | — | $1.51 | ▼ 1.63% | $1.04$2.01 |
| DRUG Bright Minds Biosciences Inc. Common Stock | $723.93M | — | $72.74 | ▼ 2.41% | $53.99$170 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Cryoport (CYRX) Q2 2026 Earnings Call TranscriptYahoo · 8/14/2026
- CryoPort (CYRX) Upgraded to Buy: Here's WhyYahoo · 8/11/2026
- Cryoport, Inc. (CYRX) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/7/2026
- Investor Confidence in CryoPort (CYRX) Strengthened Backed by Pipeline ExpansionYahoo · 8/7/2026
- Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16Benzinga · 8/7/2026
- Cryoport, Inc. Q2 2026 Earnings Call SummaryYahoo · 8/7/2026
- Needham Maintains Buy on CryoPort, Raises Price Target to $19Benzinga · 8/7/2026
- CryoPort Inc (CYRX) (Q2 2026) Earnings Call Highlights: Positive EBITDA Milestone and 15% ...Yahoo · 8/7/2026
Insider Activity
Insider Actions →Acquired
140.7K
Disposed
256.4K
- SHELTON JERRELL · August 11, 2026 · Sale28.8K @ $14.91
- ZECCHINI EDWARD J · June 11, 2026 · Option Exercise33.6K @ $4.8
- ZECCHINI EDWARD J · June 11, 2026 · Sale33.6K @ $14.47
- ZECCHINI EDWARD J · June 10, 2026 · Option Exercise1.4K @ $4.8
- ZECCHINI EDWARD J · June 10, 2026 · Sale1.4K @ $15.23
- Mandalam Ramkumar · June 8, 2026 · Sale23.2K @ $15.44
- Linda Baddour · June 5, 2026 · Grant16.1K
- Linda Baddour · June 5, 2026 · Grant10.3K
- HANCOCK DANIEL M · June 5, 2026 · Grant16.1K
- HANCOCK DANIEL M · June 5, 2026 · Grant10.3K
- Robert J. Hariri · June 5, 2026 · Grant16.1K
- Robert J. Hariri · June 5, 2026 · Grant10.3K
- Mandalam Ramkumar · June 5, 2026 · Grant16.1K
- Mandalam Ramkumar · June 5, 2026 · Grant10.3K
- STEFANOVICH ROBERT · June 4, 2026 · Sale169.4K @ $16.27
Institutional Ownership
March 31, 2026
- Total shares held
- 46.80M
- Total value held
- $375.69M
- Institutional holders
- 162
Top holders this quarter
- Unknown4.78M
- Unknown4.58M
- Unknown3.98M
- Unknown2.97M
- Unknown2.12M
- Unknown1.70M
- Unknown1.50M
- Unknown1.42M
- Unknown1.25M
- Unknown1.16M
See the full, filterable feed with live charts on the MarketWall dashboard.